Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Travere Therapeutics Inc. buy klostergang

Travere Therapeutics Inc.
Start price
€19.10
01.07.19 / 50%
Target price
€33.37
04.11.21
Performance (%)
-35.06%
End price
€12.40
17.06.21
Summary
This prediction ended on 17.06.21 with a price of €12.40. The BUY prediction by klostergang for Travere Therapeutics Inc. performed very badly with a performance of -35.06%. klostergang has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Travere Therapeutics Inc. 3.774% 3.774% 250.318% -
iShares Core DAX® -0.046% 5.960% 7.403% 65.851%
iShares Nasdaq 100 0.922% 3.693% 28.138% 93.298%
iShares Nikkei 225® 3.014% 6.638% 48.886% 89.079%
iShares S&P 500 -0.359% 2.747% 22.530% 71.942%

Comments by klostergang for this prediction

In the thread Travere Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) -35.06%
Target price 33.374
Change
Ends at 04.11.21

Retrophin mit FDA-Zulassung zur Behandlung von Cystinurie und

fortgeschrittener pipeline:

klostergang 
0
Report Share
01.07.19